Correlation Between Valneva SE and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and TC BioPharm Holdings, you can compare the effects of market volatilities on Valneva SE and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and TC BioPharm.

Diversification Opportunities for Valneva SE and TC BioPharm

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Valneva and TCBP is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Valneva SE i.e., Valneva SE and TC BioPharm go up and down completely randomly.

Pair Corralation between Valneva SE and TC BioPharm

Given the investment horizon of 90 days Valneva SE ADR is expected to generate 0.43 times more return on investment than TC BioPharm. However, Valneva SE ADR is 2.31 times less risky than TC BioPharm. It trades about 0.19 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.32 per unit of risk. If you would invest  432.00  in Valneva SE ADR on December 28, 2024 and sell it today you would earn a total of  293.00  from holding Valneva SE ADR or generate 67.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy95.0%
ValuesDaily Returns

Valneva SE ADR  vs.  TC BioPharm Holdings

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Valneva SE ADR are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Valneva SE displayed solid returns over the last few months and may actually be approaching a breakup point.
TC BioPharm Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Valneva SE and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and TC BioPharm

The main advantage of trading using opposite Valneva SE and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Valneva SE ADR and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Correlations
Find global opportunities by holding instruments from different markets